Addus HomeCare Earnings Call Highlights Profitable Growth

Addus HomeCare Corporation ((ADUS)) has held its Q1 earnings call. Read on for the main highlights of the call.

Addus HomeCare Corporation struck an upbeat tone on its latest earnings call, highlighting broad-based growth, stronger profitability and robust cash generation despite a few operational hiccups. Management emphasized that solid demand in Personal Care and Hospice, combined with tighter cost control and a cleaner balance sheet, left the company better positioned for continued expansion through 2026.

Revenue Growth Accelerates Across Core Services

Addus reported Q1 2026 revenue of $363.6 million, up 7.7% from $337.7 million a year earlier, underscoring steady expansion in its home-based care portfolio. Growth was driven mainly by Personal Care and Hospice, which together now account for more than 95% of total sales and continue to benefit from strong underlying demand.

Profitability Strengthens With Higher Adjusted EPS

Adjusted earnings per diluted share climbed 14.1% to $1.62, compared with $1.42 in Q1 2025, outpacing revenue growth and signaling improved operating efficiency. Management attributed the earnings lift to mix shifts toward higher-margin services, disciplined expense management and incremental scale benefits across the platform.

EBITDA Expansion and Margin Gains Support Upside

Adjusted EBITDA increased 9.7% year over year to $44.5 million, up from $40.6 million in the prior period, reflecting solid operating leverage. The adjusted EBITDA margin edged up to 12.2% from 12.0%, and the company reiterated expectations for full-year margin to stay above 12%, reinforcing confidence in its profitability trajectory.

Cash Flow Surges and Balance Sheet Deleverages

Operating cash flow surged to $52.4 million from $18.9 million a year earlier, giving Addus more financial flexibility for growth initiatives. The company ended Q1 with $103.1 million in cash, trimmed total bank debt to $94.3 million and maintained $547.8 million of revolver availability under a $650 million credit facility.

Personal Care Remains the Growth Engine

Personal Care revenue reached $281.1 million, representing 77.3% of total sales and rising 8.8% year over year, with same-store revenue up 6.5%. Same-store hours increased 2.2%, and daily hires improved to 108 from 103 in Q4 2025, signaling healthier staffing trends that support continued volume growth.

Hospice Segment Delivers Strong Census Growth

Hospice revenue came in at $65.8 million, or 18.1% of total revenue, with same-store growth of 7.7% versus Q1 2025. Average daily census increased 8.2% to 3,804 from 3,515, while median length of stay improved to 23 days from 19 days, pointing to stronger patient volumes and more stable utilization patterns.

Cost Discipline Drives Operational Leverage

Gross margin held steady year over year at 31.9%, showing that Addus preserved pricing and cost balance despite wage and staffing pressures. General and administrative expenses improved to 21.4% of revenue, with adjusted G&A at 19.6% versus 19.9%, demonstrating operating leverage as revenues scale.

Technology Investments Lift Productivity

Management highlighted early progress from its caregiver mobile app, now deployed in Illinois and parts of New Mexico and Texas, with rapid uptake in Texas. The tool is expected to lift service levels and caregiver engagement by making it easier to pick up shifts and hours, which should translate into higher billable hours and better utilization.

M&A Strategy Extends Geographic Reach

Addus continued to build out its footprint with the acquisition of HomeCourt Home Care in Fort Wayne, Indiana, which serves around 240 clients and generates roughly $9.7 million in annual revenue. The company also signed a definitive agreement for another Indiana personal care deal and noted it sees larger acquisition opportunities ahead, supported by its strong balance sheet.

Weather Event Temporarily Weighs on Revenue

A widespread late-January weather event disrupted personal care visits and led to an estimated $1.5 million revenue loss in the quarter, with some missed visits not fully recoverable. Management framed the impact as a transient headwind that does not alter the underlying growth trajectory of the core business.

Home Health Segment Faces Revenue Headwinds

Home Health, the company’s smallest segment, generated $16.7 million in revenue, or 4.6% of total sales, and saw organic revenue decline 6.6% year over year. Even so, management pointed to improved operating income and better sequential trends in admissions and visits, suggesting ongoing efforts to stabilize the business.

Working Capital Impact From Higher DSOs

Days sales outstanding rose to 63 days at quarter-end versus 38.2 days at the end of Q4 2025, largely due to timing changes in payment cycles. The company noted that some year-end timing issues have already been resolved and highlighted an improvement in Illinois DSOs to 47.4 days from 54.7 days, indicating progress in key markets.

Hospice Pricing Metrics Normalize

Revenue per patient day in hospice declined versus prior periods, reversing earlier gains tied to an implicit price concession benefit. Management also cited some mix effects, but emphasized that strong census growth and length-of-stay improvements remain the primary drivers of hospice performance.

One-Time Stock Compensation Distorts Comparisons

Non-cash stock-based compensation was elevated in the quarter due to accelerated vesting related to the retirement of the former President and COO. Management flagged this as a one-time adjustment, underscoring that the impact does not reflect underlying trends in ongoing compensation expenses.

Personal Care Census Sees Temporary Dip

Same-store personal care census declined slightly on a sequential basis, with management linking part of the softness to the winter weather disruptions. The company noted that census trends improved later in the quarter, particularly in Illinois, suggesting the dip was transitory rather than a sign of weakening demand.

Outlook and Margin Guidance Underpin Growth Story

Looking ahead to 2026, Addus expects adjusted EBITDA margins to remain above 12%, supported by stable gross margins around 31.9% and adjusted G&A near 19.6% of revenue. Management anticipates an effective tax rate in the mid-20% range and plans to leverage its strong cash position and sizeable revolver capacity to fund organic initiatives and selective M&A.

Addus HomeCare’s latest earnings call painted a picture of a company leaning into growth while tightening its financial profile and operational discipline. With solid revenue expansion, rising earnings, strong cash flow and a growing M&A pipeline, management appears confident that the combination of scale, technology and balance sheet strength can drive further value for investors despite isolated headwinds.